Single Stock Deep Dive
In-depth breakdowns of stock fundamentals, technicals, and valuation models — from earnings analysis to chart patterns, delivering rigorous single-stock research.
77 articles
Datadog Explained: The Monitoring King of the AI Era
Datadog (DDOG) posted Q2 2026 revenue of $1.12B, up 36% YoY, with AI products now contributing 80% of new ARR. This guide breaks down the business, valuation debate, and OpenAI customer concentration risk in plain language.
ALAB Explained: The Hidden Chip Star Behind AI Compute
Astera Labs (ALAB) is a leader in rack-scale connectivity chips for AI infrastructure, posting record Q2 2026 revenue of $392.4 million, up 104% year-over-year. This article breaks down its business, technology, valuation and key risks for investors.
Broadcom (AVGO) Investment Analysis: The Golden Era of the AI Computing "Picks and Shovels" Play
Broadcom Q2 FY2026 revenue reached $22.2 billion (+48%), AI semiconductor annualized at $56 billion (+180%), with gross margin of 67%. Custom AI chips for Google, Meta, and OpenAI command over 70% market share, while VMware software delivers near 90% gross margin. However, next-quarter guidance fell short of expectations, and the 68x P/E valuation has intensified the bull-bear divide.
IBRX Company Card: Cancer Vaccine's Cash-Burning Gamble (2026-08-18)
IBRX is an emerging biotech in immunotherapy. After Anktiva received FDA approval, revenue surged more than 10-fold, reaching $113 million in 2025. However, accumulated losses exceed $4.3 billion, shareholders' equity has turned negative, and cash burn is approximately $25 million per month. This article summarizes the company's profile, multi-year financials, valuation, and risks.
From Short Video to AI: Kuaishou 1024's Money Logic
Kuaishou is China's #2 short-video platform with Q1 2026 revenue of RMB 33.7B and DAUs surpassing 413M. This piece breaks down 1024.HK from five angles: fundamentals, business mix, the AI engine Kling, competitive landscape, valuation, and key risks.
CSOP SK Hynix 2x Daily Leveraged ETF: A Double-Edged Sword
HK-listed 07790 offers 2x daily exposure to SK Hynix, amplifying HBM upside but also decay risk over time. Best as a short-term tactical tool, not a long-term hold.
1888 Kingboard Laminates: How a CCL Giant Became Hong Kong's AI Surprise
A plain-English breakdown of 1888 Kingboard Laminates, the world's largest copper-clad laminate maker, and why its 2026 surge of over 5x made it one of the Hang Seng Composite's top performers on AI datacenter demand.
Disney Kingdom Decoded: Three Engines of Growth
Disney's latest quarter posted 7% revenue growth and 28% adjusted EPS growth, with parks setting new records. Streaming turned profitable, ESPN welcomed the NFL as a minority stakeholder, and the valuation sits near a decade low — worth a long-term look.
GitLab Explained: Undervalued AI Software Infrastructure Play?
GitLab has beaten earnings for multiple consecutive quarters with 30%+ YoY revenue growth, yet its stock still trades around the low $30s. This article breaks down what GitLab actually does, how AI is reshaping its business, the insider signals, and how different time-horizon investors should think about it.
Breaking Down SMCI Super Micro: An AI Server Meme Stock Reborn by Earnings
SMCI Super Micro Computer saw its stock soar nearly 20% in a single day, fueled by AI server orders and FY27 revenue guidance of $65B–$72B. However, historical accounting controversies, margin normalization, and share dilution remain three major risks. This article uses plain language to dissect SMCI's business logic, the truth behind its financials, and the risks investors should weigh before buying or selling.
HPE's Explosive Run: AI Infrastructure Veteran Reborn
From $22 in March to $60 in August — what's driving HPE's massive rally? This piece breaks down HPE's business model, recent price action, AI server orders, the Juniper acquisition effect, and the overbought risks to watch — all explained in plain language.
DELL Explained: How the PC King Became an AI Infrastructure Darling
Dell has evolved from a PC brand into a key AI server vendor riding the hyperscaler capex wave. This article breaks down Dell's business mix, the logic behind the recent push to $500, competitive risks against SMCI and HPE, and what investors should watch.
IREN Explained: Bitcoin Miner to AI Cloud Powerhouse
IREN (Iris Energy) rebranded itself from a renewable-energy Bitcoin miner into an AI Cloud provider in just over a year, riding a $9.7B Microsoft contract and 4.5GW of secured power. This article breaks down IREN's business, Q2 FY26 results, capital structure, valuation, and three key risks.
NBIS Simply Explained: The AI Compute Newcomer
NBIS (Nebius) is an AI cloud provider spun off from Russia's Yandex, renting Nvidia GPU compute to AI companies. Q2 2026 revenue surged 454% year-over-year with customer prepayments projected to exceed $9B, but active compute capacity sits at only ~0.3GW. This piece breaks down the company's story, financial highlights, hidden risks, and valuation in plain language.
Uber Stock Analysis: Is the 26% Drop a Buying Opportunity?
Uber shares fell nearly 26% from the 52-week high of $101.99 to around $75, yet quarterly earnings surged 85% YoY and the analyst consensus target sits at $101. This piece breaks down whether the pullback is a dip-buying opportunity or a falling knife.
KTOS Explained: The Drone-Maker Defense Stock on the Rise
KTOS (Kratos Defense) is a mid-cap U.S. defense contractor specializing in drones, hypersonic systems, space, and target aircraft. After recently securing roughly $400M in hypersonic program funding, the stock has become a hot topic on Wall Street. This article breaks down its business model, recent catalysts, valuation, and key risks in plain language.
HIMS Explained Simply: Beyond Men's Wellness, A Telehealth Story
A plain-language breakdown of Hims & Hers Health (HIMS) — how the subscription telehealth business really makes money, why the GLP-1 weight-loss segment is both its growth engine and its biggest risk, and what the FTC lawsuit means for the stock going forward.
From $1 to $4.7: What Is TMCI? A Plain-English Guide to Treace Medical's Comeback and Risks
TMCI is a foot-and-ankle orthopedic medical device company whose Lapiplasty system treats bunions; its stock has surged from $1.17 to as high as $7.78 before settling at $4.76 over the past year. This article walks through its business, earnings, lawsuits, technicals, and valuation so you can understand the logic and risks behind this small-cap medical device story.
Eli Lilly LLY: How a Weight-Loss Drug Reshaped Pharma
Eli Lilly (LLY) has become the world's most valuable pharma stock, powered by GLP-1 blockbusters Mounjaro and Zepbound. Q2 2026 revenue hit $22.97B, with FY guidance raised to $85-87B. This article breaks down its business, valuation, technical setup, and key risks.
RKLB Is More Than a Rocket Company: Inside Rocket Lab's Full-Stack Space Ambition
From a $397M Space Force Flatellite contract on Aug 5 and a $266M Air Force HASTE deal in July, to the Iridium acquisition and Neutron rocket's first flight, RKLB is evolving from a launch provider into a defense space prime. This piece breaks down its business model, backlog, insider signals, and the upcoming Q2 earnings catalyst.
Page 1 / 4, 77 articles